Clinical Trials Logo

Ventilator Associated Pneumonia clinical trials

View clinical trials related to Ventilator Associated Pneumonia.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 3

NCT ID: NCT02632539 Not yet recruiting - Clinical trials for Ventilator Associated Pneumonia

Air-impingement Manipulation to Clear Subglottic Secretion to Prevent VAP in Prolonged Intubated Patients

Start date: January 2016
Phase: Phase 3
Study type: Interventional

Ventilator-associated pneumonia (VAP) is the most frequent infection occurring in patients who are admitted to the ICU. The accumulation of respiratory secretions in the subglottic space is a well-proven cause of VAP. Investigators invented a manual method with high-flow air produced by resuscitator to impinge secretion from the subglottic space to oral cavity. Investigators want to compare it with conventional method which uses a special intubation tube with an independent dorsal lumen to suction subglottic secretion.

NCT ID: NCT01798537 Not yet recruiting - Bacteremia Clinical Trials

Simplified Selective Digestive Tract Decontamination for the Prevention of Intensive Care Unit Acquired Infections

SDDICU
Start date: June 2013
Phase: Phase 2/Phase 3
Study type: Interventional

A simplified graded gut decontamination protocol combined with rigorous bi-weekly screening and appropriate bacterial prophylaxis, will lead to a 25% reduction in the acquisition of blood stream infections and to a 25% reduction in lower airway colonization with multi drug resistant organisms. There will be no concomitant rise in gram-positive or fungal infection or a surgency of new resistance patterns.

NCT ID: NCT01501227 Not yet recruiting - Clinical trials for Ventilator Associated Pneumonia

Ventilator Associated Pneumonia in Taper Guard Versus Normal Tube in ICU Patients

Start date: February 2012
Phase: Phase 4
Study type: Interventional

Ventilator associated pneumonia ( VAP) adds burden to the care of the intensive care patients as they may cause the death of the patient or prolong the intensive care stay or complicate the illness in other ways. The risk of infection is dependent on the interplay between bacteria load into the lungs and the immune status. There has been a lot of focus on bacteria load reduction and this includes the use of subglottic suctioning in an attempt to reduce the amount of bacteria that may move into the lungs. The Hi Lo tubes which were designed to allow subglottic suctioning was significantly effective in reducing the incidence of ventilator associated pneumonia compared to normal tubes. A new generation of endotracheal tubes that not only incorporate subglottic suctioning but provide a more snug fit into the tracheal by a new tapering design may be even more useful to provide the solution for bacterial load reduction. Conventional tubes which may furrow on themselves to allow the creation of microchannels may aid microaspiration. The taper guard which has facilities for subglottic suctioning as well as the strategy to reduce furrowing to the minimum may be the answer to the problem of ventilator associated pneumonia. This study is to determine the extent of protection this tube has against ventilator associated pneumonia compared with conventional endotracheal tubes